Total Payments
$106,187
2024 Payments
$1,724
Companies
63
Transactions
850
Medicare Patients
13,911
Medicare Billing
$1.2M
Payment Breakdown by Category
Other$75,030 (70.7%)
Food & Beverage$19,809 (18.7%)
Travel$5,248 (4.9%)
Consulting$5,195 (4.9%)
Education$878.08 (0.8%)
Gifts$27.78 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $72,830 | 46 | 68.6% |
| Food and Beverage | $19,809 | 749 | 18.7% |
| Travel and Lodging | $5,248 | 26 | 4.9% |
| Consulting Fee | $5,195 | 3 | 4.9% |
| Honoraria | $1,200 | 1 | 1.1% |
| Grant | $1,000 | 1 | 0.9% |
| Education | $878.08 | 23 | 0.8% |
| Gift | $27.78 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $17,806 | 54 | $0 (2023) |
| Grifols USA, LLC | $14,405 | 41 | $0 (2024) |
| GlaxoSmithKline, LLC. | $14,228 | 66 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $13,014 | 25 | $0 (2024) |
| Mylan Specialty L.P. | $5,020 | 15 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $4,603 | 40 | $0 (2024) |
| Gilead Sciences, Inc. | $4,539 | 54 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $4,474 | 68 | $0 (2024) |
| Shire North American Group Inc | $4,329 | 12 | $0 (2018) |
| ViiV Healthcare Company | $4,240 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,724 | 74 | Actelion Pharmaceuticals US, Inc. ($337.45) |
| 2023 | $1,266 | 61 | Philips Electronics North America Corporation ($154.26) |
| 2022 | $2,203 | 92 | Philips Electronics North America Corporation ($504.33) |
| 2021 | $6,009 | 68 | Grifols USA, LLC ($2,738) |
| 2020 | $15,960 | 81 | Bayer HealthCare Pharmaceuticals Inc. ($5,920) |
| 2019 | $29,109 | 166 | GlaxoSmithKline, LLC. ($8,831) |
| 2018 | $25,134 | 166 | Genentech USA, Inc. ($7,733) |
| 2017 | $24,781 | 142 | Genentech USA, Inc. ($6,044) |
All Payment Transactions
850 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: RESPIRATORY | ||||||
| 12/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Vifor Pharma, Inc. | Zemaira (Drug) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 12/04/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Cardio-pulmonary | ||||||
| 11/07/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.59 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2024 | Digestive Care, Inc. | Pertzye (Drug), Pertzye, Pertzye | Food and Beverage | Cash or cash equivalent | $28.15 | General |
| Category: Gastroenterology | ||||||
| 09/20/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/17/2024 | Resmed Corp | AIRSENSE (Device) | Food and Beverage | Cash or cash equivalent | $15.19 | General |
| Category: Sleep | ||||||
| 09/17/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $8.20 | General |
| Category: Cardiology | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/29/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $15.28 | General |
| Category: Narcoplepsy | ||||||
| 08/22/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Respiratory | ||||||
| 08/20/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $16.61 | General |
| Category: HFCWO | ||||||
| 08/20/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $6.62 | General |
| Category: HFCWO | ||||||
| 08/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.96 | General |
| 08/15/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $20.92 | General |
| Category: Narcoplepsy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 3,884 | 5,529 | $980,931 | $348,765 |
| 2022 | 30 | 3,790 | 4,902 | $890,720 | $306,996 |
| 2021 | 20 | 3,039 | 3,969 | $734,622 | $252,342 |
| 2020 | 27 | 3,198 | 4,351 | $725,856 | $257,558 |
Total Patients
13,911
Total Services
18,751
Medicare Billing
$1.2M
Procedure Codes
99
All Medicare Procedures & Services
99 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 477 | 1,468 | $190,840 | $91,591 | 48.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 459 | 624 | $118,560 | $58,798 | 49.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 344 | 398 | $161,190 | $54,371 | 33.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 445 | 604 | $96,640 | $38,907 | 40.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 327 | 338 | $50,700 | $14,249 | 28.1% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 324 | 334 | $70,140 | $13,380 | 19.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 109 | 109 | $28,885 | $12,915 | 44.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 186 | 312 | $31,406 | $12,308 | 39.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 90 | 95 | $26,125 | $9,811 | 37.6% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 448 | 493 | $46,835 | $9,665 | 20.6% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 344 | 391 | $37,145 | $9,528 | 25.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 49 | 66 | $13,806 | $6,216 | 45.0% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 71 | 77 | $43,890 | $4,978 | 11.3% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 34 | 39 | $22,959 | $3,791 | 16.5% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 70 | 70 | $14,000 | $2,543 | 18.2% |
| 32555 | Aspiration of fluid from chest cavity using imaging guidance | Facility | 2023 | 17 | 19 | $9,442 | $1,643 | 17.4% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 23 | 23 | $10,350 | $1,392 | 13.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 16 | 16 | $2,240 | $1,055 | 47.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $2,418 | $883.46 | 36.5% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 15 | 16 | $1,920 | $418.40 | 21.8% |
| 71045 | X-ray of chest, 1 view | Office | 2023 | 11 | 12 | $780.00 | $240.48 | 30.8% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 12 | 12 | $660.00 | $82.56 | 12.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 508 | 722 | $137,180 | $69,583 | 50.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 403 | 905 | $121,025 | $50,603 | 41.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 189 | 205 | $83,025 | $31,401 | 37.8% |
About Dr. Daniel Layish, M.D
Dr. Daniel Layish, M.D is a Internal Medicine healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659350320.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Layish, M.D has received a total of $106,187 in payments from pharmaceutical and medical device companies, with $1,724 received in 2024. These payments were reported across 850 transactions from 63 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($72,830).
As a Medicare-enrolled provider, Layish has provided services to 13,911 Medicare beneficiaries, totaling 18,751 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 99 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Sleep Medicine
- Location Orlando, FL
- Active Since 01/11/2006
- Last Updated 12/01/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1659350320
Products in Payments
- Esbriet (Biological) $17,487
- Adempas (Drug) $13,014
- TRELEGY ELLIPTA (Drug) $12,327
- Prolastin-C (Biological) $9,091
- Prolastin-C Liquid (Biological) $5,314
- Yupelri (Drug) $4,947
- GLASSIA (Biological) $3,879
- Letairis (Drug) $3,722
- STIOLTO RESPIMAT (Drug) $3,408
- SUNOSI (Drug) $3,066
- Creon (Drug) $1,774
- GIAPREZA (Drug) $1,427
- ANORO (Drug) $1,407
- (8874) inCourage (Device) $1,156
- BOTOX (Biological) $1,000
- inCourage (Device) $794.16
- UPTRAVI (Drug) $635.60
- OFEV (Drug) $587.55
- Arikayce (Drug) $548.34
- ARALAST (Biological) $525.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Orlando
Dr. Shahram Mori, Md, MD
Internal Medicine — Payments: $983,741
Internal Medicine $983,741
Michel Velez, Md, MD
Internal Medicine — Payments: $837,815
Internal Medicine $837,815
Dr. Rushang Patel, M.d, Ph.d, M.D, PH.D
Internal Medicine — Payments: $347,712
Internal Medicine $347,712
Dr. Jason Korenblit, M.d, M.D
Internal Medicine — Payments: $294,920
Internal Medicine $294,920
Kwabena Ayesu, Md, MD
Internal Medicine — Payments: $265,751
Internal Medicine $265,751
Dennis Yang, Md, MD
Internal Medicine — Payments: $203,483
Internal Medicine $203,483